Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone augmentation vs placebo in early sertraline treatment for PTSD
2005-000223-42Phase 2Active
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in post-traumatic stress disorder (PTSD) and major depressive disorder (MDD) comparing Sertraline + ziprasidone with Sertraline + placebo (2 arms). Primary endpoints: Posttraumatic Diagnostic Scale score and Beck Depression Inventory score. Started Nov 2005; status: active.
02
Drugs
ziprasidone
03
Conditions
post-traumatic stress disorder (PTSD)major depressive disorder (MDD)
Beyond the preview
Go deeper on 2005-000223-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000223-42.